Found 8 matching trials
A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938)
PHASE3When a patient with Parkinson's disease (PD) is initially treated with L-do...
Location
Multiple Locations
Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)
PHASE2This study was designed to determine if preladenant (SCH 420814, MK-3814) c...
Location
Multiple Locations
Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)
PHASE3This is a study of the efficacy and safety of preladenant in adult particip...
Location
Multiple Locations
Dyskinesia in Parkinson's Disease (Study P04501)
PHASE2The purpose of the study is to assess the efficacy and safety of a range of...
Location
Multiple Locations
Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)
PHASE2This study is designed to evaluate the effectiveness of preladenant in the ...
Location
Multiple Locations
A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)
PHASE2This study is to evaluate the efficacy of a range of preladenant doses comp...
Location
Multiple Locations
An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)
PHASE3The primary purpose of this extension study is to assess the long-term safe...
Location
Multiple Locations
Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)
PHASE1This is a randomized, placebo-controlled, 3-period crossover, balanced, sin...
Location
Multiple Locations